Physiologically active substances
US7256178B2 · kind B2 · utility
7Cited by
1References
39Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jul 31, 2003 |
| Grant date | Aug 14, 2007 |
| Priority date | — |
| Expiry date | Jul 31, 2023 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12P17/162
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds represented by the following general formula (I), pharmacologically acceptable salts thereof or hydrates of the same: (I) wherein W representsand R3, R7, R16, R17, R20, R21 and R21′ are the same or different and each represents hydrogen, etc. Because of inhibiting angiogenesis and inhibiting the production of VEGF particularly in hypoxia, the compounds (I) are useful as remedies for solid cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.